Hansoh Pharmaceutical Group Company Limited (HK:3692) has released an update.
At the recent annual general meeting, Hansoh Pharmaceutical Group Company Limited announced unanimous shareholder approval for all proposed resolutions, including the adoption of the 2023 financial statements and the election of board members. Shareholders also endorsed a final dividend payment for 2023 and approved general mandates for the repurchase and issuance of company shares. This overwhelming support reflects strong confidence in the company’s leadership and future direction.
For further insights into HK:3692 stock, check out TipRanks’ Stock Analysis page.
